top of page
Laronix achieves Australian and US regulatory milestones
7 February 2022
Laronix is incredibly excited to achieve another milestone on its journey in providing a true voice for laryngectomy people. Laronix Voice-Box now listed in FDA and the Australian Register of Therapeutic Goods.
​
Laronix voice-box is now included on the Australian Register of Therapeutic Goods (ARTG), meaning we have achieved our regulatory milestone to access the US and Australian markets.​
​
​The ARTG inclusion together with our device previously listed with the FDA, is a major milestone achievement for our team, our laryngectomee friends, and our future Australian and US roll-out.
bottom of page